UAE to reopen labor market for Bangladeshis ‘very soon’: Envoy

The UAE is the second-largest destination for Bangladeshis in the Mideast. (Reuters)
Short Url
Updated 01 February 2020

UAE to reopen labor market for Bangladeshis ‘very soon’: Envoy

  • The ambassador said on Thursday that the group would be made up of UAE Ministry of Human Resources and Emiratization members and relevant officials from Bangladesh

DHAKA: The UAE is to reopen its labor market to Bangladeshi migrant workers “very soon” after an eight-year block, Bangladesh’s envoy to the country has revealed.

Muhammad Imran, who was on Wednesday honored with one of the UAE’s highest civilian decorations, told Arab News that a joint technical group would be working to iron out “procedural issues” allowing the process to take place.

The ambassador said on Thursday that the group would be made up of UAE Ministry of Human Resources and Emiratization members and relevant officials from Bangladesh.

He added that the UAE government had made assurances on the matter to Bangladeshi Prime Minister Sheikh Hasina during her visit to Abu Dhabi in mid-January.

Imran noted that he had been given further assurances on the manpower export issue during his most recent discussions with the UAE Minister of Foreign Affairs Abdullah bin Zayed but added that Emirati authorities had “some concerns” regarding the skills and security of Bangladeshi workers. “We are working on these issues and hope to settle all things shortly,” he said.

The UAE is the second-largest destination for Bangladeshi migrant workers in the Middle East after Saudi Arabia.

Shameem Ahmed Chowdhury Noman, secretary-general of the Bangladesh Association of International Recruiting Agencies (BAIRA), said there were currently around 500,000 Bangladeshis employed in the UAE.

“Since the UAE stopped receiving Bangladeshi workers in 2012, it’s been tough to track the exact numbers of Bangladeshi migrants over there. But I think it will be around half-a-million,” Noman told Arab News.

“For reopening the labor market, we are now working on the terms of reference and expect to start the manpower export process by the (end of) first quarter of this year,” he added.

Currently, the UAE receives a limited number of Bangladeshi migrant workers as domestic helps and drivers.

Meanwhile, during a ceremony on Wednesday, the Medal of Independence of the First Order was presented to Imran by Al-Nahyan in recognition of his efforts toward promoting relations and cooperation between the two countries.


France halts hydroxychloroquine for coronavirus treatment

Updated 27 May 2020

France halts hydroxychloroquine for coronavirus treatment

  • The move came after two French advisory bodies and the World Health Organization warned this week that the drug had been shown to be potentially dang
  • The drug is also used to treat malaria

PARIS: The French government on Wednesday banned treatment of COVID-19 patients with hydroxychloroquine, a controversial and potentially harmful drug that US President Donald Trump has said he is taking preventively.
The move came after two French advisory bodies and the World Health Organization warned this week that the drug — a treatment for rheumatoid arthritis and lupus — had been shown to be potentially dangerous in several studies.
The urgency of the coronavirus outbreak has prompted some doctors to prescribe the drug despite a lack of research to demonstrate its efficacy against the coronavirus.
Among them were a French infectious disease specialist who caught the ear of Trump, who stunned his own administration last week by revealing he was taking hydroxychloroquine as a preventive measure against COVID-19.
Under the new French rules, the drug can be used only in clinical trials to test its efficacy against coronavirus — making it unclear if the French doctor, Didier Raoult, would be able to continue using it at his hospital in Marseille in the south.
Raoult has already rejected a comprehensive study published last week in The Lancet medical journal, which found that administering hydroxychloroquine or its related compound chloroquine actually increased the risk of dying for many patients.
Hydroxychloroquine, also used to treat malaria, is sold under the brand name Plaquenil by French pharma giant Sanofi, which promised to offer governments millions of doses if studies proved it could be safely used in the coronavirus fight.